In Vivo Gene Delivery Using Exosomes Engineered to Contain AAV Improves Transduction Efficiency and Resists Neutralizing Antibodies

被引：0
|
作者：
McConnell, Russell [1 ]
Lule, Sevda [1 ]
Zi, Tong [1 ]
Jang, Su Chul [1 ]
Noyes, Aaron [1 ]
Sathy, Sriram [1 ]
机构：
[1] Codiak BioSci, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
461
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [1] Vesicle-Cloaked AAV Resists Neutralizing Antibodies In Vivo
    Fitzpatrick, Zachary
    Mu, Dakai
    Maguire, Casey A.
    MOLECULAR THERAPY, 2014, 22 : S23 - S23
  • [2] Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo
    Gyoergy, Bence
    Fitzpatrick, Zachary
    Crommentuijn, Matheus H. W.
    Mu, Dakai
    Maguire, Casey A.
    BIOMATERIALS, 2014, 35 (26) : 7598 - 7609
  • [3] AAVs Meet Exosomes: Exosomal AAVs for Shielding Neutralizing Antibodies and Improved Cardiac Gene Delivery in vivo
    Adamiak, Marta
    Asadi, Morad
    Liang, Yaxuan
    Jha, Divya
    Wills, Lauren
    Mathiyalagan, Prabhu
    Agarwal, Neha
    Kohlbrenner, Erik
    Jeong, Dongtak
    Ceholski, Delaine K.
    Dubois, Nicole
    Hajjar, Roger J.
    Sahoo, Susmita
    CIRCULATION, 2019, 140
  • [4] Confirmatory detection of neutralizing antibodies to AAV gene therapy using a cell-based transduction inhibition assay
    Kasprzyk, Theresa
    Triffault, Sabrina
    Long, Brian R.
    Zoog, Stephen J.
    Vettermann, Christian
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 24 : 222 - 229
  • [5] Chemically-Engineered AAV Vectors: How Chemistry Improves AAV Liver Gene Delivery
    Lalys, Pierre-Alban
    Bouzelha, Mohammed
    Pavageau, Karine
    Alvarez-Dorta, Dimitri
    Bourdon, Audrey
    Gouin, Sebastien
    Jaulin, Nicolas
    Guilbaud, Mickael
    Le Guiner, Caroline
    Adjali, Oumeya
    Deniaud, David
    Mevel, Mathieu
    MOLECULAR THERAPY, 2022, 30 (04) : 70 - 70
  • [6] Impacts of Pre-Existing Antibodies on Transduction Efficiency of Systemic AAV9 Gene Delivery: Potential for Broader Patient Eligibility for AAV Gene Therapy
    Meadows, Aaron S.
    Pineda, Ricardo
    Fu, Haiyan
    MOLECULAR THERAPY, 2018, 26 (05) : 102 - 103
  • [7] AAV-Containing Exosomes as a Novel Vector to Improve AAV-Mediated Myocardial Gene Delivery in Resistance to Neutralizing Antibody
    Liang, Yaxuan
    Mathiyalagan, Prabhu
    Kohlbrenner, Erik
    Chepurko, Elena
    Jeong, Dongtak
    Ceholski, Delaine
    Dubois, Nicole
    Hajjar, Roger
    Sahoo, Susmita
    CIRCULATION, 2017, 136
  • [8] Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
    Vercauteren, Koen
    Hoffman, Brad E.
    Zolotukhin, Irene
    Keeler, Geoffrey D.
    Xiao, Jing W.
    Basner-Tschakarjan, Etiena
    High, Katherine A.
    Ertl, Hildegund C. J.
    Rice, Charles M.
    Srivastava, Arun
    de Jong, Ype P.
    Herzog, Roland W.
    MOLECULAR THERAPY, 2016, 24 (06) : 1042 - 1049
  • [9] In Vivo Quantification Of Photoreceptor Transduction Efficiency Using Novel Modified AAV Capsids
    Ryals, Renee
    Kay, Christine
    Boye, Sanford
    Min, Seok-Hong
    Ayala, Andrea
    Hauswirth, William
    Boye, Shannon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [10] Continued In Vitro and In Vivo Characterization of Novel AAV Vectors Engineered for Muscle Gene Delivery
    Green, Jennifer
    Willacy, Tiffany
    Boehler, Jessica
    Dhruva, Alina
    Meng, Hui
    Beatka, Margaret
    Ott, Emily
    Prom, Mariah
    Lawlor, Michael W.
    Pechan, Peter
    Morris, Carl
    MOLECULAR THERAPY, 2021, 29 (04) : 159 - 159
12345